XivaMD
XivaMD
XivaMD designs and manufactures medical devices, runs a digital health and AI platform, makes and sells pharmaceuticals, and funds the research that connects all three.
We bring high-quality healthcare solutions to market, offering a comprehensive portfolio designed to meet the rigorous standards of modern medicine. We supply advanced medical devices, diagnostic equipment, surgical instruments, implants, disposables, consumables, and orthopedic and prosthetic devices. Every product bearing the XivaMD name—whether manufactured in-house or sourced through our trusted global and domestic partnerships—strictly adheres to the Medical Device Rules, 2017.
Through strategic warehousing, rigorous testing, and robust supply chain management, we ensure consistent availability and seamless domestic and international distribution.
We build and operate a digital healthcare platform — apps, websites and software — that lets patients, doctors, hospitals, diagnostic centres, pharmacies and insurers reach and manage care digitally: telemedicine and teleconsultation, remote patient monitoring, electronic health records, health information exchange, and appointment and hospital-management systems.
Underneath that platform sits our AI and data work — researching, building, licensing and commercially using artificial intelligence, machine learning, analytics and cloud tools for diagnostics, disease prediction, clinical decision support, medical imaging, drug discovery and patient engagement.
Health data we hold is collected, stored and processed under the Digital Personal Data Protection Act, 2023, with security and privacy infrastructure built into the platform.
XivaMD manufactures, formulates, imports, exports and sells pharmaceutical products — drugs, medicines, nutraceuticals, biologicals and vaccines — across allopathic, ayurvedic, homeopathic and other recognised systems of medicine, under the licences the Drugs and Cosmetics Act, 1940 requires for each product and site.
We also own and run pharmacies — retail, wholesale and online — to get those products to patients. Every outlet is licensed and staffed by a registered pharmacist, as the Pharmacy Act requires.
Every other part of the business depends on research we fund and run ourselves. XivaMD sets up R&D centres, laboratories and testing facilities in India and abroad, sponsors and commercialises research into devices, pharmaceuticals and AI, and files for the patents, trademarks, designs and other IP that research produces.
Where a device or medicine needs clinical evidence before it reaches patients, we run or support clinical trials, clinical evaluations and post-market surveillance, under the regulatory approvals each requires.
What holds it together
Manufacturing, software, medicine and research don't run on their own. These are the capabilities we build alongside them.
Storage, warehousing, cold-chain logistics and transport, plus installation, servicing, calibration and maintenance of devices already in the field.
Healthcare consultancy, training and continuing medical education for professionals, hospitals and institutions we work with.
Leasing and renting medical equipment to hospitals, clinics and diagnostic centres on a managed-equipment basis.
Clinical trials, clinical evaluations and post-market surveillance for our devices and pharmaceutical products.
Technical collaborations, joint ventures, licensing and technology-transfer agreements with partners in India and abroad.
Collecting, storing and processing health data under the Digital Personal Data Protection Act, 2023, with security infrastructure built in.
Diagnostic laboratories, pathology and imaging centres, and preventive-health and wellness check-up services.
How the company is structured
XivaMD is set up not just to run these four businesses, but to fund, grow and, where it makes sense, spin them apart.
The company can raise funds through equity, debt or other permitted instruments, and invest surplus funds back into the business as it grows.
XivaMD can acquire, hold shares in, or amalgamate with other companies working in allied or related fields, as the business consolidates or expands.
Devices, pharmaceuticals, digital health and data each sit under their own regulator — CDSCO, the Drugs & Cosmetics Act, and the DPDP Act among them. Each business is licensed on its own terms, not on the strength of this one.
India’s healthcare challenges run deep—from missing equipment to delayed diagnoses. We believe the solution is integration: keeping manufacturing, software, medicine, and research unified inside a single company for seamless care. — XivaMD Private Limited